Latest News and Events in ASI
Download our mobile app:
World’s First FDA-Cleared ALK Automated Analysis Instrument
GenASIs Scan & Analysis ALK is a solution for computer aided detection of ALK gene rearrangements in non-small cell lung cancer (NSCLC) and is used as an aid in identifying ALK-positive NSCLC patients eligible for treatment with Xalkori® (Crizotinib)
Go-Path - Pathology Imaging and Analysis
GenASIs Go-Path introduces major enhancements to ASI’s newly introduced GenASIs 7.2 imaging and analysis platforms, positioning ASI as a leader in computer aided pathology immunohistochemistry analysis for cancer and other IHC applications.
Quality Analysis When Tissue is the Issue